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Abstract 
Many low- and middle-income countries, together with remote and low socioeconomic 
populations within high-income countries, lack the resources and services to deal with cancer. 
The challenges in upgrading or introducing the necessary services are enormous, from screening 
and diagnosis to radiotherapy planning/treatment and quality assurance. There are severe 
shortages not only in equipment, but also in the capacity to train, recruit and retain staff as well 
as in their ongoing professional development via effective international peer-review and 
collaboration. Here we describe some examples of emerging technology innovations based on 
real-time software and cloud-based capabilities that have the potential to redress some of these 
areas. These include: (i) automatic treatment planning to reduce physics staffing shortages, (ii) 
real-time image-guided adaptive radiotherapy technologies, (iii) fixed-beam radiotherapy 
treatment units that use patient (rather than gantry) rotation to reduce infrastructure costs and 
staff-to-patient ratios, (iv) cloud-based infrastructure programmes to facilitate international 
collaboration and quality assurance and (v) high dose rate mobile cobalt brachytherapy 
techniques for intraoperative radiotherapy. 
 
Introduction 
There is a well-documented, urgent, global demand for technologically simpler, affordable, 
locally sustainable solutions for delivering safe and effective external beam radiotherapy [1], [2], 
[3]. Current approaches are unable to provide economical and well-supported technologies, 
particularly in low- and middle-income countries where cancer rates are highest, staff shortages 
are the most severe and resources are severely limited [1]. The outcome of this is little or no 
access to treatment in 55 countries and shortages in 80 others [2]. Even in the developed world, 
the tyranny of distance caused by geographically dispersed patient populations (for example in 
Canada, Australia and the UK) means that the conventional model of highly centralised 
radiotherapy networks has resulted in significantly reduced rates of radiotherapy utilisation and 
access to care as a function of the distance away from a centre that a patient lives [4], [5], [6], 
[7], [8], [9], [10]. 
 
The recommended minimum infrastructure requirements from International Atomic Energy 
Agency (IAEA) guidelines for a basic radiotherapy centre are: a teletherapy unit, a 
brachytherapy unit, a mould room, a simulator and some basic dosimetric quality assurance 
equipment [11]. For staffing, the minimum IAEA recommendations are one treatment planner 
per 300 patients and one radiation physicist per 400 patients receiving treatment annually [11]. It 
is estimated that, by 2020, low- and middle-income countries will have deficits of about 10 000 
teletherapy units, 12 000 radiation oncologists, 10 000 medical physicists, and 29 000 radiation 
therapy technologists [2], [11]. These estimates are based on data sets in the public domain (e.g. 
IAEA), with staffing levels based on recommendations from the European Society for 
Radiotherapy & Oncology and IAEA [12]. Hence, there is a crucial need for radiation therapy 
staff at all levels, in addition to the need for corresponding training and ongoing professional 
development for these individuals. The training burden is enormous: for medical physicists, most 
guidelines recommend a 2–3 year internship or residency, often after completion of medical 
physics graduate school [13], [14], [15]. Although various educational initiatives bring young 
radiation oncologists and medical physicists from low- and middle-income countries to academic 
cancer centres in high-income countries, they are often insufficient in addressing the current and 
future staffing deficits [16]. Furthermore, the failure of professionals who receive training in a 
high-income country to return home after training in the high-income countries is a historical 
challenge in radiation oncology and other fields [17], [18], [19]. 
 
Developing and executing on innovative and locally sustainable radiotherapy solutions requires 
co-operation and co-ordination between academia, hospital, government, private enterprise and 
non-governmental organisations. There are many marvellous recent examples that serve to 
highlight the impact strong collaborations can have on redressing the staggering global 
underutilisation of radiotherapy (e.g. [20], [21]). 
 
Here we describe some innovative technology developments across the radiotherapy ecosystem 
with the potential to provide treatments with affordable state-of-the-art technology. Utilising 
real-time control systems, automation and cloud-based infrastructure that is now widely available 
allows lean innovation in radiotherapy technology with the potential to deliver affordable 
solutions that are neither obsolete nor second-rate [22], [23] and enables collaboration across 
borders. Each of these innovations targets a different part of the radiotherapy treatment 
ecosystem but all aim to transform global access to safe, high-quality, accurate radiotherapy. 
 
Automated Planning 
In many countries, the roles of treatment planner and medical radiation physicist are combined. 
In some countries, planning responsibilities even fall to radiation oncologists [12]. For both of 
these scenarios, fully automated treatment planning could reduce the severe workforce shortages 
of medical physicists and radiation oncologists [11]. Automated planning requires a much-
reduced skillset compared with manual planning, meaning that training requirements could be 
considerably lowered and that lesser skilled staff could manage routine planning activities. 
 
Before 2000, much work was spent on automation of treatment-planning decisions in 
conventional radiotherapy, such as determining wedge filters and beam weights [24], [25] and 
beam orientations [26]. With the emergence of intensity-modulated radiotherapy (IMRT) [27], 
[28], [29], most of these efforts were redirected to the automatic delineation of normal tissues 
and targets [30], [31] and plan optimisation [27], [32]. However, the clinical introduction of 
automated treatment planning overall has been slow. The many reasons for this include the 
complexity of several advanced treatments (e.g. IMRT) that have become the standard of care in 
high-resource settings, and the requirements for these treatments (e.g. accuracy of normal tissue 
delineation) can be very high. A recent point/counterpoint article [33] in the journal Medical 
Physics debated whether, within the next 10 years, treatment planning will become fully 
automated without the need for human intervention. The arguments against automated treatment 
planning were focused on examples of treatments that remain difficult to automate, such as 
bilateral post-implant chest wall irradiation. There are, however, many simpler clinical situations 
that are possible to fully automate. Examples include four-field box treatments used to treat 
cervical cancer, which a group at The University of Texas MD Anderson Cancer Centre has 
automated as part of a project to create a radiation planning assistant for automatically planning 
patients for low-resource settings [34]. Their approach, illustrated via a process-oriented 
workflow in Figure 1, uses standardised treatment approaches to automatically create radiation 
plans for cervix, breast and head/neck treatments, including automatic secondary checks of many 
of the planning tasks, including contouring [35]. 
Although automated treatment planning has yet to be fully realised in a clinical setting, it will 
probably occur within 5 years. Much of the necessary research and development has already 
taken place, leaving the essential steps of integration (into a commercial planning system), 
deployment and training. Such an achievement could realise significant reductions in the number 
of physicists needed for planning purposes. 
 
Real-time Adaptive Image-guided Radiotherapy 
The inclusion of image guidance and adaptation enables a change in the patient set-up paradigm, 
from the current iterative external/internal alignment to a patient adaptive approach. Currently, 
patients are typically set-up for treatment using one or a combination of room lasers, indexing 
systems and X-ray imaging. The patient position is measured, corrected and often measured 
again before treatment. In the patient adaptive approach, variations in the patient position, inter- 
and intrafraction changes can be dosimetrically accounted for, even for large displacements. For 
example, for conformal prostate radiotherapy, patient positioning shifts of up to 10 cm could be 
robustly adapted to via geometry-based adaptation [36] and intrafraction organ motion of 2 cm 
could be similarly accounted for [37]. For IMRT it has been shown that, with geometry-based 
adaptation, plan quality was maintained despite target rotations of up to five degrees and 
translations up to 15 mm [38]. Having the system adapt to the patient, rather than adapting the 
patient to the system, will improve workflow when automation is sufficiently fast. 
 
Marker-based real-time image guidance has been a clinical reality in real-time radiotherapy and 
CyberKnife [39] systems for over a decade and has recently been implemented on a single-kV 
imager gantry rotating system [40]. For widespread use, real-time image-guided radiotherapy 
will probably need markerless solutions. A variety of kV-based and MV-based solutions have 
been proposed [39], [41], [42], [43]. Much work is going into the broader clinical translation for 
these promising markerless methods. Once the real-time image-guided radiotherapy system 
determines the tumour location, the task of real-time adaptation to this motion can be achieved 
via multileaf collimator (MLC) tracking or couch tracking. MLC tracking technology has been 
clinically implemented for translational target tracking [44] and has been shown in phantom 
cases to account for tumour rotation [45] and deformation [46]. Couch tracking has been 
investigated in several studies, but has yet to be clinically implemented [47], [48], [49]. A 
recently published comparison of four tracking technologies (CyberKnife, Vero, MLC and couch 
tracking) showed that all systems are capable of highly accurate target delivery in the presence of 
motion, and that large treatment errors resulted when motion was not explicitly accounted for 
[50]. 
 
Real-time image guidance has been implemented on widely available systems. Both MLC and 
couch tracking capabilities are software adaptations to these widely available solutions. 
 
Fixed-beam Radiotherapy Treatment Units using Real-time Adaptive Image-guided 
Radiotherapy 
Simplified gantry designs are emerging for magnetic resonance imaging–linac therapy, proton 
and ion therapy, and medical applications of synchrotron radiation [51], [52], [53]. In all cases, 
the engineering complexities associated with rotating the treatment gantries (rather than the 
patients) are either impractical or very costly [54]. Patient rotation is in clinical use at a few 
specialised centres [55], [56], [57] with a number of other seated rotation solutions now 
emerging on the market. Both vertical and horizontal patient rotation solutions are also under 
development for MV photon radiotherapy applications [59], [60], [61]. The size, surface area 
footprint and shielding requirements for the horizontal patient rotation solution have been 
estimated to be three times smaller than a typical linac available on the global market today [59]. 
Real-time, adaptive, image-guided therapies (described above) allow for curative treatments 
including stereotactic body radiation therapy (SBRT) and volumetric modulated arc therapy, 
while relaxing some of the patient alignment (and hence staff-to-patient ratio) requirements. 
Delivering hypofractionated image-guided radiotherapy treatments allows for increased patient 
throughput. Fixed-beam linacs could deliver superior treatments at the same cost level as existing 
low-cost radiotherapy units available in some low- and middle-income countries. 
 
The Nano-X Tatum Horizontal Patient Rotation Solution 
Nano-X Tatum is one solution under development for a fixed-beam linac using horizontal patient 
rotation [52], [54], [59] and on-board imaging capabilities to enable real-time image-guided 
motion management. The hardware for this system will comprise five main components, the 
minimum requirements for each being: (i) 6 MV linear accelerator, (ii) MLC tracking capability, 
(iii) MV electronic portal imaging device detector, (iv) kV imaging source and detector, (v) 
patient rotation pod and (vi) real-time control of all of the above. 
 
The Nano-X Tatum patient rotation pod is shown in Figure 2. The principal criteria for the pod 
design were safety, real-time control, short treatment times and patient comfort and tolerance. 
Patient and user safety are ensured through triple redundancies in communication, interlocks, 
emergency stops and manual override protocols. Short treatment times are enabled through fast 
(1 min) patient ingress and egress. Immobilising primary straps and secondary pneumatic air 
bags facilitate patient comfort and tolerance. Once commissioning of the pod is complete, it will 
be integrated with a refurbished linac for end-to-end pre-clinical demonstration. 
Gravitational Motion and Deformation 
Patient rotation challenges conventional image guidance and immobilisation techniques, while 
reducing the size, cost and service burden of a rotating gantry. The gravitational effects on 
anatomy caused by immobilised horizontal rotation are now being investigated with pre-clinical 
and preliminary work suggesting deformation is at most two to three times larger than the 
relatively small deformation caused by respiratory motion. Real-time image guidance and 
adaptation will be used to maintain treatment quality, which in a general sense means that a 
larger fraction of patients can be offered shorter-course hypofractionated treatments. Patient 
motion will be minimised with semi-automated set-up and immobilisation. Nano-X machines 
will adapt in real-time for all residual motion and deformation. 
 
Nano-X Treatment Workflow 
Patients are scanned on a conventional computed tomography planning system and their 
treatment plan is calculated. Patients are transferred into the Nano-X pod and immobilised. A 
pre-treatment cone-beam computed tomography is acquired by rotating the patient once. These 
steps all align with the conventional protocol for modern radiotherapy with on-board imaging 
capabilities. Volumetric images of the patient anatomy at each treatment angle are reconstructed 
(for IMRT and conformal treatments; volumetric modulated arc therapy treatments are dealt with 
slightly differently). The planning computed tomography volume is warped with correct 
correspondence to the volumetric cone-beam computed tomography and the treatment plan is 
adapted accordingly. Patients are treated with the adapted plan and residual tumour motion can 
then be monitored and adapted with real-time adaptive techniques similar to those described 
above. 
 
Cloud-based Collaboration for Radiotherapy Clinical Trials, Research and Training 
Interobserver variability in target delineation is by far the single largest systematic uncertainty in 
the delivery of accurate radiotherapy [64], [65]. Proactive collaboration and expert peer review 
across international borders, together with strict credentialing and data quality assurance 
requirements, could go a long way in facilitating international harmonisation and better patient 
outcomes through training, credentialing and international clinical trials with faster accrual of 
patient cohorts [66]. 
 
A remotely accessible cloud-based electronic platform (CEP) has been developed to facilitate 
collaboration among radiation oncologists around the world [67]. The platform is secure and 
efficient and appeals to experts from diverse populations and demographics. A patient’s data 
created at one institution are immediately available for review at another institution using only a 
web browser. Immediate feedback between the institutions occurs, facilitating uniformity across 
clinics irrespective of geographical location. This not only ensures trial protocol compliance and 
high standards of uniformity, but also facilitates training and credentialing regardless of 
geographical location. 
 
The Cloud-based Electronic Platform 
The CEP specifically confronts the issue of peer review of advanced radiotherapy planning and 
delivery techniques in the pursuit of international collaboration across borders regardless of 
socioeconomic status. Cloud-based collaboration has the potential to significantly improve 
quality, safety and accessibility of advanced radiotherapy techniques and enhance capabilities of 
institutions in global health research and training. It provides an environment in which radiation 
oncologists worldwide can receive, share and analyse multimodality data to facilitate expert 
review, second opinion and international clinical trials in radiotherapy. 
 
The CEP requires minimum local operational resources. It stores all data in a cloud while making 
it possible to cache data locally for full-offline operations, obviating the need for local backup of 
data. The CEP meets the following design criteria: 
(i) Users securely upload and download imaging from modalities including 
computerised tomography, magnetic resonance imaging, secondary capture, digital 
radiography, portal images and digitally reconstructed radiography as well as 
radiotherapy data objects (DICOM, scanned images, treatment plans, etc.). 
 
(ii) Data are automatically registered and entered into a database and are never 
overwritten. 
 
(iii) Patient confidentiality is maintained throughout the process. A hierarchical privilege-
based remote access is available for users of the system. 
 
(iv) Submitted clinical data are processed automatically and made immediately available 
to download worldwide using a web browser and custom-built application. 
 
(v) Data objects are annotatable on a graphic user interface with the support of data 
authoring and versioning control. 
 
 
Figure 3a shows the process-oriented view of the CEP events from the users’ perspective. 
Clinical data flow from treatment planning systems and/or imaging devices to a local PC that 
runs the data processing application (DPA) software. DPA software anonymises and encrypts 
radiotherapy data and uploads it to the cloud server via web services. An electronic notification 
is immediately sent in the form of an email with a URL to the reviewer/s from a stored list in the 
DPA software. This URL takes them directly to the web portal containing information on all 
accessible data for that patient. The submitted data become immediately logged into an 
electronic folder, which can be viewed by the reviewer either via a web browser in the cloud for 
rapid review or by downloading it from the cloud to a local PC for an in-depth review. Both 
options are provided to cope with varied and variable network bandwidths. The Microsoft 
Silverlight ‘thin client’ interface allows instant web-based access to DICOM images, secondary 
capture images and pertinent treatment planning information. The data review tools are adequate 
for the review of delineated anatomy and include zoom, pan, measure, window and level, 
annotate, turn ‘on/off’ segmented structure overlays and drawing tools. Figure 3b shows an 
example of a web page emulating the desired functionalities of a peer review tool. 
High Dose Rate Co-60 Brachytherapy for Intraoperative Radiotherapy 
Co-60 has recently been incorporated for use in high dose rate (HDR) brachytherapy [68], [69] 
and is commercially available integrated in an afterloader [70]. Co-60 HDR brachytherapy 
afterloaders offer clinically established treatments for many type of cancers (head and neck 
cancers, endobronchial and oesophageal cancers, gynaecological cancers, breast cancers and 
prostate cancer). Because Co-60 HDR brachytherapy afterloader machines only require a source 
exchange every 5 years, they significantly reduce the operating and logistical overheads 
associated with other available HDR afterloaders using, for example, Ir-192, which require a 
source exchange every 3 months [20]. 
 
Another innovation of Co-60 HDR is in the integration of afterloader machines with mobile units 
for mobile intraoperative radiotherapy (IORT). IORT is well established and can be delivered 
using these systems in a variety of malignancies, especially when primary tumour control has a 
critical implication for patient morbidity and quality of life [71], [72]. HDR IORT treatments are 
delivered after resection of the tumour. A single large radiation dose is delivered to the tumour 
bed or margin at risk for local failure while excluding or limiting the dose to adjacent sensitive 
organs and structures. HDR IORT treatments could be a useful replacement option for when 
access to external beam radiotherapy is limited (Figure 4). 
The use of Co-60 HDR afterloader machines would require special attention to shielding 
requirement and logistics. They can only be operated in shielded Co-60 rooms or shielded 
operating rooms where the number of HDR procedures performed per week should be taken into 
consideration. 
 
Conclusion 
Here we have described several examples of innovative technology developments across the 
radiotherapy ecosystem. These examples are all linked by a shared hypothesis that by moving the 
complexities of technology from hardware and staffing to automation and software, it becomes 
possible to re-imagine global access to safe, high-quality, accurate and locally sustainable 
radiotherapy with software approaches, real-time algorithms and cloud-based capabilities. The 
examples described in this paper are by no means exhaustive, representing only a small selection 
of many innovations at various stages of clinical realisation that can be directed to improve 
cancer care in underserved regions. The ability to execute on innovative technology 
developments unquestionably requires collaboration and coordination between academia, 
hospital, government, private enterprise and non-governmental organisations with a shared 
vision and short-term, mid-term and long-term strategies. 
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Fig 1. Workflow for an automated treatment planning system (radiotherapy planning assistant) 
being developed at The University of Texas MD Anderson Cancer Center. The people icons 
indicate where user interaction is needed. All other steps are automated. 
 
 
 
 
  
  
Fig 2. Nano-X Tatum rotation pod stages from ingress to imaging-ready position: (a) ingress at a 
comfortable sitting height, (b) lies down in supine position and primary restraints secured, (c) 
pneumatic airbag systems provide secondary immobilisation and patient comfort and security. 
  
  
Fig 3. (a) Process-oriented view of the set of events of the cloud-based electronic platform 
(CEP). (b) A web page that emulates some of the desired functionalities of the CEP. 
  
  
 
Fig 4. A mobile high dose rate brachytherapy treatment system could be used for intraoperative 
radiotherapy: (a) brachytherapy treatment planning system on a mobile platform, (b) an example 
of a HAM applicator inserted in the abdominal cavity for a colorectal cancer case, (c) another 
example of a HAM applicator stitched inside the neck for a head and neck cancer. 
 
